Viewing Study NCT01599559

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 3:03 PM

Ignite Modification Date: 2025-12-28 @ 12:09 PM

Study NCT ID: NCT01599559

Status: ACTIVE_NOT_RECRUITING

Last Update Posted: 2024-10-24

First Post: 2012-05-10

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma

Sponsor: International Extranodal Lymphoma Study Group (IELSG)

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module